Literature DB >> 12551993

G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.

Ali Amara1, Aurore Vidy, Genevieve Boulla, Karine Mollier, Javier Garcia-Perez, Jose Alcamí, Cedric Blanpain, Marc Parmentier, Jean-Louis Virelizier, Pierre Charneau, Fernando Arenzana-Seisdedos.   

Abstract

The requirement of human immunodeficiency virus (HIV)-induced CCR5 activation for infection by R5 HIV type 1 (HIV-1) strains remains controversial. Ectopic CCR5 expression in CD4(+)-transformed cells or pharmacological inhibition of G(alpha)i proteins coupled to CCR5 left unsolved whether CCR5-dependent cell activation is necessary for the HIV life cycle. In this study, we investigated the role played by HIV-induced CCR5-dependent cell signaling during infection of primary CD4-expressing leukocytes. Using lentiviral vectors, we restored CCR5 expression in T lymphocytes and macrophages from individuals carrying the homozygous 32-bp deletion of the CCR5 gene (ccr5 Delta32/Delta32). Expression of wild-type (wt) CCR5 in ccr5 Delta32/Delta32 cells permitted infection by R5 HIV isolates. We assessed the capacity of a CCR5 derivative carrying a mutated DRY motif (CCR5-R126N) in the second intracellular loop to work as an HIV-1 coreceptor. The R126N mutation is known to disable G protein coupling and agonist-induced signal transduction through CCR5 and other G protein-coupled receptors. Despite its inability to promote either intracellular calcium mobilization or cell chemotaxis, the inactive CCR5-R126N mutant provided full coreceptor function to several R5 HIV-1 isolates in primary cells as efficiently as wt CCR5. We conclude that in a primary, CCR5-reconstituted CD4(+) cell environment, G protein signaling is dispensable for R5 HIV-1 isolates to actively infect primary CD4(+) T lymphocytes or macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551993      PMCID: PMC141084          DOI: 10.1128/jvi.77.4.2550-2558.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Chemokines and HIV replication.

Authors:  H Schmidtmayerova; B Sherry; M Bukrinsky
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

2.  Selective G protein coupling by C-C chemokine receptors.

Authors:  Y Kuang; Y Wu; H Jiang; D Wu
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; A Cara; R C Gallo; P Lusso
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

Review 5.  Generation of high-titer pseudotyped retroviral vectors with very broad host range.

Authors:  J K Yee; T Friedmann; J C Burns
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

6.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.

Authors:  E Oberlin; A Amara; F Bachelerie; C Bessia; J L Virelizier; F Arenzana-Seisdedos; O Schwartz; J M Heard; I Clark-Lewis; D F Legler; M Loetscher; M Baggiolini; B Moser
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

7.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

8.  Differential regulation of G-protein-mediated signaling by chemokine receptors.

Authors:  H Arai; I F Charo
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

9.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

10.  The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.

Authors:  M Alfano; H Schmidtmayerova; C A Amella; T Pushkarsky; M Bukrinsky
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

View more
  32 in total

1.  Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.

Authors:  Wan-Lin Wu; Christopher Robert Grotefend; Ming-Ting Tsai; Yi-Ling Wang; Vladimir Radic; Hyungjin Eoh; I-Chueh Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.

Authors:  Philippe Colin; Yann Bénureau; Isabelle Staropoli; Yongjin Wang; Nuria Gonzalez; Jose Alcami; Oliver Hartley; Anne Brelot; Fernando Arenzana-Seisdedos; Bernard Lagane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

Review 3.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

4.  Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa.

Authors:  Maud Deruaz; Thomas T Murooka; Sophina Ji; Marc A Gavin; Vladimir D Vrbanac; Judy Lieberman; Andrew M Tager; Thorsten R Mempel; Andrew D Luster
Journal:  JCI Insight       Date:  2017-04-06

5.  Measuring the subcellular compartmentalization of viral infections by protein complementation assay.

Authors:  Juliette Fernandez; Cédric Hassen-Khodja; Virginie Georget; Thierry Rose; Yves Jacob; Yves L Janin; Sébastien Nisole; Pierre-Olivier Vidalain; Nathalie J Arhel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

6.  The nectin-1alpha transmembrane domain, but not the cytoplasmic tail, influences cell fusion induced by HSV-1 glycoproteins.

Authors:  Ravi P Subramanian; Jennifer E Dunn; Robert J Geraghty
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

7.  Matrix and envelope coevolution revealed in a patient monitored since primary infection with human immunodeficiency virus type 1.

Authors:  Elodie Beaumont; Daniela Vendrame; Bernard Verrier; Emmanuelle Roch; François Biron; Françis Barin; Fabrizio Mammano; Denys Brand
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

8.  Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion.

Authors:  S E Pontow; N Vander Heyden; S Wei; L Ratner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.

Authors:  Yuntao Wu; Alyson Yoder
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

10.  The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.

Authors:  Dongyang Yu; Weifeng Wang; Alyson Yoder; Mark Spear; Yuntao Wu
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.